Read about Enteris BioPharma oral drug delivery news and innovation via press releases, press coverage, & upcoming events.
- PEPTIDE THERAPEUTICS – Oral Peptide Therapeutics – Opportunities Abound as Barriers FallProteins and peptides are the building blocks of life and are a very promising basis for targeting a range of diseases. Throughout the past 30 years, and especially the past 10 years, there has been a rapid growth in the development of therapeutic proteins, with a significant increase in the number of protein-based drugs on ...
- EXECUTIVE INTERVIEW – Enteris BioPharma: Pioneers in Oral Formulation DevelopmentBreaking down the barriers to oral delivery of peptides and small molecules is no easy task, but it holds the key to enhancing myriad drug products and treatment paradigms.
- Peptelligence® Technology enables oral delivery of peptides and expands patient accessA clinical-stage biopharmaceutical company focused on peptide therapies for the treatment of several unmet medical needs recognized that developing its lead asset solely as an injectable would ultimately limit the drug’s market penetration and patient acceptance.
